We are delighted to be part of two successful CF-Trust/LifeArc Innovation Hubs, based at the University of Liverpool and Manchester, funded as part of a network four innovation hubs in a £15M investment into changing the lives of people living with cystic fibrosis.
The network will be made up of four Innovation Hubs, led by the Universities of Cambridge, Liverpool, Manchester and Imperial College London, as well as partners across the UK and overseas from 2024 to 2029.
Guided by insights and experiences of people with cystic fibrosis, the new CF Innovation Hubs will address new ways to detect, diagnose, treat and manage lung infections and lung health and help to overcome some of the barriers that can prevent scientists from turning their discoveries into real outcomes for patients.
We will be contributing our proteomics expertise, and be rejoined by Dr Rosie Maher, who will be returning to us with her clinical proteomics experience from her prior CF work to deliver this research in January.
For more information please read more on the CF Trust site here.
Comments are closed, but trackbacks and pingbacks are open.